Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients

Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients

Blog Article

BACKGROUND: Hypertension (HTN) is the most prevalent non-infectious disease worldwide and can lead to mortality.This trial aimed to compare the effect of N-acetylcysteine (NAC) and angiotensin-converting enzyme inhibitors (ACEIs) on controlling blood pressure in hypertensive patients.METHODS: This cross-sectional clinical trial was conducted in Hajar Hospital, welding sweater Shahrekord, Iran, in 2009.

A sample of 126 patients with HTN was selected and randomly divided into 2 groups (group A and group B).First, group A was treated with ACEI alone and group B with ACEI + NAC for 2 months.Blood pressure of all patients was evaluated each week.

After a 2 week period of washout, the drugs were changed.In the second period of the trial, group A was treated with click here ACEI + NAC and group B with NAC alone and their blood pressure was evaluated in the same manner as the previous period.The data were analyzed using SPSS.

RESULTS: A significant reduction was observed in systolic and diastolic blood pressure of patients (P < 0.050).However, during both periods of the trial, the group receiving NAC + ACEI experienced a more significant reduction in blood pressure compared with the ACEI group (P < 0.

050).CONCLUSION: NAC accompanied with ACEI decreased the patients’ systolic and diastolic blood pressure significantly; however, ACEI alone did not have any significant effects on blood pressure.Systolic blood pressure decreased 7 mmHg on average and fluctuated during the trial.

   Normal 0 false false false EN-US X-NONE AR-SA.